195 related articles for article (PubMed ID: 10549126)
1. [Potentials risks in drug prevention of thrombosis--low-molecular-weight heparin versus standard heparin].
Ganzer D; Gutezeit A; Mayer G
Z Orthop Ihre Grenzgeb; 1999; 137(5):457-61. PubMed ID: 10549126
[TBL] [Abstract][Full Text] [Related]
2. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P
Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523
[TBL] [Abstract][Full Text] [Related]
3. [Heparin-induced thrombocytopenia after elective hip joint replacement with postoperative prevention of thromboembolism with low-molecular-weight heparin].
Marx A; Huhle G; Hoffmann U; Wang LC; Schüle B; Jani L; Harenberg J
Z Orthop Ihre Grenzgeb; 1999; 137(6):536-9. PubMed ID: 10666863
[TBL] [Abstract][Full Text] [Related]
4. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
Míka P; Behounek J; Skoták M; Nevsímal L
Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
[TBL] [Abstract][Full Text] [Related]
5. [Heparin induced thrombocytopenia type II after the use of low-molecular weight heparin. Case report and review of the literature].
Franke J; Schaeper O; Kayser R; Mahlfeld K
Unfallchirurg; 2003 Jan; 106(1):77-81. PubMed ID: 12552397
[TBL] [Abstract][Full Text] [Related]
6. [Significance and incidence of type II heparin-induced thrombocytopenia. A prospective study].
Mahlfeld K; Böck M; Franke J; Meinecke I; Schaeper O; Kayser R; Grasshoff H
Zentralbl Chir; 2001 Jan; 126(1):39-43. PubMed ID: 11227292
[TBL] [Abstract][Full Text] [Related]
7. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
8. Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery?
Lubenow N; Hinz P; Ekkernkamp A; Greinacher A
Eur J Haematol; 2007 Sep; 79(3):187-90. PubMed ID: 17655709
[TBL] [Abstract][Full Text] [Related]
9. [Prevention of thrombosis with unfractionated and low molecular weight heparin].
Breddin HK
Wien Med Wochenschr; 1989 Dec; 139(23):555-9. PubMed ID: 2560285
[TBL] [Abstract][Full Text] [Related]
10. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
[TBL] [Abstract][Full Text] [Related]
11. An improved definition of immune heparin-induced thrombocytopenia in postoperative orthopedic patients.
Warkentin TE; Roberts RS; Hirsh J; Kelton JG
Arch Intern Med; 2003 Nov; 163(20):2518-24. PubMed ID: 14609790
[TBL] [Abstract][Full Text] [Related]
12. A prospective observational study on the effectiveness and safety of bemiparin, first dose administered 6 h after knee or hip replacement surgery.
Abad JI; Gómez-Outes A; Martínez-González J; Rocha E;
Arch Orthop Trauma Surg; 2007 Oct; 127(8):665-70. PubMed ID: 17089172
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effectiveness and safety of low-molecular weight heparin versus unfractionated heparin anticoagulation after heart valve surgery.
Bucci C; Geerts WH; Sinclair A; Fremes SE
Am J Cardiol; 2011 Feb; 107(4):591-4. PubMed ID: 21184996
[TBL] [Abstract][Full Text] [Related]
14. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
[TBL] [Abstract][Full Text] [Related]
15. [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients].
Omran H; Hammerstingl C; Paar WD;
Med Klin (Munich); 2007 Oct; 102(10):809-15. PubMed ID: 17928964
[TBL] [Abstract][Full Text] [Related]
16. [Heparin-induced thrombocytopenia as a complication of postoperative prevention of thromboembolism with unfractionated heparin/low molecular weight heparin after hip and knee prosthesis implantation].
Mahlfeld K; Franke J; Schaeper O; Kayser R; Grasshoff H
Unfallchirurg; 2002 Apr; 105(4):327-31. PubMed ID: 12066471
[TBL] [Abstract][Full Text] [Related]
17. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
Whang PG; Lieberman JR
Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
[TBL] [Abstract][Full Text] [Related]
18. [Heparin-induced thrombocytopenia in patients and prevention with low molecular weight heparin].
Kormanová K; Krska Z; Trca S; Pesková M; Korínková P
Sb Lek; 2001; 102(3):419-25. PubMed ID: 12092129
[TBL] [Abstract][Full Text] [Related]
19. Prevention of postoperative thromboembolism with Enoxaparin in general surgery: a German multicenter trial.
Haas S; Flosbach CW
Semin Thromb Hemost; 1993; 19 Suppl 1():164-73. PubMed ID: 8395721
[TBL] [Abstract][Full Text] [Related]
20. [Heparin-induced thrombocytopenia. Diagnosis, clinical course and therapeutic alternatives].
Scheffold N; Maitra R; Cyran J
Schweiz Med Wochenschr; 1998 Apr; 128(16):609-15. PubMed ID: 9611303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]